Qvintip is now on Facebook! Please Like us on www.facebook.com/qvintip
Qvintip started to be delivered to Lithuania and is now available on the market through laboratory chains
Aprovix will present Qvintip in Siberia to Russia’s leading gynecologists.
In the frame of Cervical Cancer International Forum, Moscow Radisson Slavyanskaya, Aprovix CEO Lana Obolenskaja presented the Qvintip solution in front of leading Russian and International experts
Lana Obolenskaja, has been appointed as CEO of Aprovix AB. Lana has a background from management positions in marketing and regulatory affairs in pharmaceutical industry. Lana takes over the role from Bengt Falk, PhD, who will continue his engagement in the company as Chairman of the board.
A group of Finnish private investors have subscribed to new shares in a directed share issue, thereby securing financial resources for investment in primarily marketing and sales, as well as further product development.
During the annual shareholders meeting in October, following the share issue, Aprovix shareholders unanimously elected a new board, now consisting of Bengt Falk, Chairman, Leena Niemistö and Ariel Nemes representing the new investors in the company, as well as re-electing Sven Mattsson.